Multiple Sclerosis (MS), a chronic inflammatory disease of the central nervous system that
leads to demyelination and neurodegeneration has been associated with various …

Abstract Introduction Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a
complex multisystem disease characterised by severe and disabling new-onset symptoms of …

Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous system. An
increase in MS incidence over time is reported in several regions of the world. We aimed to …

Objective To explore whether age at onset increased over time despite a shortened interval
from the initial clinical demyelinating event to the diagnosis of multiple sclerosis (MS), as …

Growing evidence supports significant involvement of immune dysfunction in the etiology of
neurodegenerative diseases, several of which also display prominent sex differences across …

Multiple sclerosis (MS) is a chronic immune-mediated, inflammatory, and degenerative
disease that is up to three times more frequent in young women. MS does not alter fertility …

Background: A diagnosis of multiple sclerosis (MS) can be categorized based on its disease
course into the following phenotypes: relapsing-remitting MS (RRMS), primary progressive …

Multiple sclerosis is associated with Epstein–Barr virus (EBV) infection, B‐cell dysfunction,
gut dysbiosis, and environmental and genetic risk factors, including female sex. A disease …

Background The Greater Hobart region (42.5° S) of Tasmania has consistently had the
highest recorded prevalence and incidence rates of multiple sclerosis (MS) in Australia. We …

The immunological mechanisms that contribute to multiple sclerosis (MS) differ between
males and females. Females are 2–3 times more likely to develop MS compared to males …